JBIO
Jade Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$13.83
+2.67%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-34.8%
Return on equity
-32.5%
Return on assets
-37.4%
Return on invested capital
0.00x
Asset turnover
-$123.5M
Cash from operations
$7.25
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026